[go: up one dir, main page]

AU2000265051A1 - Vasoactive intestinal peptide analogs - Google Patents

Vasoactive intestinal peptide analogs

Info

Publication number
AU2000265051A1
AU2000265051A1 AU2000265051A AU6505100A AU2000265051A1 AU 2000265051 A1 AU2000265051 A1 AU 2000265051A1 AU 2000265051 A AU2000265051 A AU 2000265051A AU 6505100 A AU6505100 A AU 6505100A AU 2000265051 A1 AU2000265051 A1 AU 2000265051A1
Authority
AU
Australia
Prior art keywords
peptide analogs
vasoactive intestinal
intestinal peptide
vasoactive
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000265051A
Inventor
Neena Gupta
Archna Mathur
Rama Mukherjee
Sudhanand Prasad
Anu T. Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dabur Research Foundation
Original Assignee
Dabur Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dabur Research Foundation filed Critical Dabur Research Foundation
Publication of AU2000265051A1 publication Critical patent/AU2000265051A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/17—Vasoactive intestinal peptides; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2000265051A 2000-02-18 2000-07-31 Vasoactive intestinal peptide analogs Abandoned AU2000265051A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN136/DEL/2000 2000-02-18
IN136DE2000 2000-02-18
PCT/US2000/020871 WO2001060862A1 (en) 2000-02-18 2000-07-31 Vasoactive intestinal peptide analogs
US09/630,335 US6489297B1 (en) 2000-02-18 2000-07-31 Vasoactive intestinal peptide analogs

Publications (1)

Publication Number Publication Date
AU2000265051A1 true AU2000265051A1 (en) 2001-08-27

Family

ID=26324877

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000265051A Abandoned AU2000265051A1 (en) 2000-02-18 2000-07-31 Vasoactive intestinal peptide analogs

Country Status (4)

Country Link
US (2) US6489297B1 (en)
EP (1) EP1257576B1 (en)
AU (1) AU2000265051A1 (en)
WO (1) WO2001060862A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2515892C (en) 2003-02-14 2012-10-23 Children's Hospital & Research Center At Oakland Lipophilic drug delivery vehicle and methods of use thereof
WO2006106528A1 (en) * 2005-04-07 2006-10-12 Dabur Pharma Limited Novel peptides useful for treatment of alopecia
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
JP2009525946A (en) 2005-12-20 2009-07-16 デューク・ユニヴァーシティ Methods and compositions for delivering active agents with enhanced pharmacological properties
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
US8268796B2 (en) 2008-06-27 2012-09-18 Children's Hospital & Research Center At Oakland Lipophilic nucleic acid delivery vehicle and methods of use thereof
CN105727261A (en) 2008-06-27 2016-07-06 杜克大学 Therapeutic agents comprising elastic peptides
KR101943420B1 (en) 2009-08-14 2019-04-17 파세비오 파마수티컬스 인코포레이티드 Modified Vasoactive Intestinal Peptide
WO2012161755A2 (en) 2011-02-02 2012-11-29 Emory University Antagonism of the vip signaling pathway
WO2012170524A1 (en) 2011-06-06 2012-12-13 Phasebio Pharmaceuticals, Inc. Use of modified vasoactive intestinal peptides in the treatment of hypertension
US9458217B2 (en) 2013-12-05 2016-10-04 Emory University Methods of managing graft versus host disease
AU2015255752B2 (en) 2014-05-08 2020-07-23 Immunoforge Co., Ltd. Methods and compositions for treating Cystic Fibrosis
JP6824888B2 (en) 2015-02-09 2021-02-03 フェーズバイオ ファーマシューティカルズ，インコーポレイテッド Methods and compositions for treating muscle disorders and disorders
ES2957890T3 (en) 2016-04-08 2024-01-29 Univ Emory Methods for treating cancer and infectious diseases using cell therapies
WO2019094817A1 (en) * 2017-11-10 2019-05-16 Emory University Nanoparticles conjugated with vasoactive intestinal peptide antagonists
WO2019209952A2 (en) 2018-04-23 2019-10-31 Emory University Vip antagonists and uses in treating cancer

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605641A (en) 1984-10-09 1986-08-12 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs
US4734400A (en) 1984-10-09 1988-03-29 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs
GB8525852D0 (en) 1985-10-19 1985-11-20 Beecham Group Plc Compounds
US4835252A (en) 1987-02-26 1989-05-30 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
US5141924A (en) 1989-06-30 1992-08-25 Hoffmann-La Roche, Inc. Synthetic vasoactive intestinal peptide analogs
EP0463450B1 (en) 1990-06-26 1994-02-16 Sanwa Kagaku Kenkyusho Co., Ltd. Vasoactive intestinal polypeptide analogues and use thereof
US5217953A (en) 1990-11-30 1993-06-08 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Vasoactive intestinal peptide antagonist
US5849261A (en) 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
JPH05238950A (en) 1991-04-22 1993-09-17 Sanwa Kagaku Kenkyusho Co Ltd Readily absorbable vip pharmaceutical
AU656230B2 (en) 1991-10-11 1995-01-27 F. Hoffmann-La Roche Ag Cyclic vasoactive peptides
US5565424A (en) 1994-02-07 1996-10-15 Ramot - University Authority For Applied Research And Industrial Development Ltd. Superactive VIP antagonists
AU682638B2 (en) * 1995-06-09 1997-10-09 ILS, Inc. Peptide, bronchodilator and blood flow ameliorant
US5955574A (en) 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
EP0835662B1 (en) 1996-10-08 2001-11-14 National Institute of Immunology A drug for the treatment of cancer
ES2335827T3 (en) * 1998-07-20 2010-04-05 Ipsen Pharma PACAP PEPTIDAL ANALOGS.

Also Published As

Publication number Publication date
US20030158110A1 (en) 2003-08-21
US7094755B2 (en) 2006-08-22
WO2001060862A1 (en) 2001-08-23
US6489297B1 (en) 2002-12-03
EP1257576A1 (en) 2002-11-20
EP1257576B1 (en) 2004-09-15

Similar Documents

Publication Publication Date Title
GB0014870D0 (en) Peptides
AU2000265051A1 (en) Vasoactive intestinal peptide analogs
AU2002360487A1 (en) Acyclovir-peptide analogs
AU2001251321A1 (en) Vancomycin analogs
AU2002222176A1 (en) Time synchronisation
GB0029777D0 (en) Peptides
AU2001240791A1 (en) Sequence
HK1042307A1 (en) Peptide having preptin functionality
IL150458A0 (en) Novel haptotactic peptides
AU2001288220A1 (en) Hyperglycosylated polypeptides
PL366425A1 (en) Peptide compounds
GB0001825D0 (en) Peptides
AU6550800A (en) Hepoxilin analogs
AU2001280120A1 (en) Cyclic peptide derivative
AU2001278975A1 (en) Alpha-conotoxin peptides
AU2001286165A1 (en) Peptide mimetics
AUPQ386899A0 (en) Peptide compounds
AU2659801A (en) Shc associated protein 140 (sap-140)
GB0007263D0 (en) Peptides
AU2001290317A1 (en) Novel peptides
AU2001292059A1 (en) Nicastrin protein
AUPR112700A0 (en) Peptide nitroanilides
AU2002232176A1 (en) Cyclic peptide
AU2002328853A1 (en) Carcinoma-related peptides
AU2002327896A1 (en) Peptide screen